TY - BOOK AU - Swerdlow, S. H. AU - Campo, E. AU - Harris, N. L. AU - Jaffe, E. S. AU - Pileri, S. A. AU - Stein, H. PY - 2008 DA - 2008// TI - WHO classification of tumours of hematopoietic and lymphoid tissue PB - IARC CY - Lyon ID - Swerdlow2008 ER - TY - JOUR AU - James, C. AU - Ugo, V. AU - Couedic, J. P. AU - Staerk, J. AU - Delhommeau, F. AU - Lacout, C. PY - 2005 DA - 2005// TI - A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera JO - Nature VL - 434 UR - https://doi.org/10.1038/nature03546 DO - 10.1038/nature03546 ID - James2005 ER - TY - JOUR AU - Pikman, Y. AU - Lee, B. H. AU - Mercher, T. AU - McDowell, E. AU - Ebert, B. L. AU - Gozo, M. PY - 2006 DA - 2006// TI - MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia JO - PLoS Medicine VL - 3 UR - https://doi.org/10.1371/journal.pmed.0030270 DO - 10.1371/journal.pmed.0030270 ID - Pikman2006 ER - TY - JOUR AU - Li, B. AU - Gale, R. P. AU - Xiao, Z. PY - 2014 DA - 2014// TI - Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia JO - Journal of Hematology & Oncology. VL - 7 UR - https://doi.org/10.1186/s13045-014-0093-1 DO - 10.1186/s13045-014-0093-1 ID - Li2014 ER - TY - JOUR AU - Nangalia, J. AU - Massie, C. E. AU - Baxter, E. J. AU - Nice, F. L. AU - Gundem, G. AU - Wedge, D. C. PY - 2013 DA - 2013// TI - Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2 JO - The New England Journal of Medicine VL - 369 UR - https://doi.org/10.1056/NEJMoa1312542 DO - 10.1056/NEJMoa1312542 ID - Nangalia2013 ER - TY - JOUR AU - Piazza, R. AU - Valletta, S. AU - Winkelmann, N. AU - Redaelli, S. AU - Spinelli, R. AU - Pirola, A. PY - 2013 DA - 2013// TI - Recurrent SETBP1 mutations in atypical chronic myeloid leukemia JO - Nature Genetics VL - 45 UR - https://doi.org/10.1038/ng.2495 DO - 10.1038/ng.2495 ID - Piazza2013 ER - TY - JOUR AU - Martinez-Aviles, L. AU - Besses, C. AU - Alvarez-Larran, A. AU - Torres, E. AU - Serrano, S. AU - Bellosillo, B. PY - 2012 DA - 2012// TI - TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2- and MPL-negative myeloproliferative neoplasms JO - Annals of Hematology VL - 91 UR - https://doi.org/10.1007/s00277-011-1330-0 DO - 10.1007/s00277-011-1330-0 ID - Martinez-Aviles2012 ER - TY - JOUR AU - Klampfl, T. AU - Gisslinger, H. AU - Harutyunyan, A. S. AU - Nivarthi, H. AU - Rumi, E. AU - Milosevic, J. D. PY - 2013 DA - 2013// TI - Somatic mutations of calreticulin in myeloproliferative neoplasms JO - The New England Journal of Medicine VL - 369 UR - https://doi.org/10.1056/NEJMoa1311347 DO - 10.1056/NEJMoa1311347 ID - Klampfl2013 ER - TY - JOUR AU - Barbui, T. AU - Finazzi, G. AU - Falanga, A. PY - 2013 DA - 2013// TI - Myeloproliferative neoplasms and thrombosis JO - Blood VL - 122 UR - https://doi.org/10.1182/blood-2013-03-460154 DO - 10.1182/blood-2013-03-460154 ID - Barbui2013 ER - TY - JOUR AU - Cervantes, F. AU - Passamonti, F. AU - Barosi, G. PY - 2008 DA - 2008// TI - Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders JO - Leukemia VL - 22 UR - https://doi.org/10.1038/leu.2008.72 DO - 10.1038/leu.2008.72 ID - Cervantes2008 ER - TY - JOUR AU - Finazzi, G. AU - Stefano, V. AU - Barbui, T. PY - 2013 DA - 2013// TI - Are MPNs vascular diseases? JO - Current Hematologic Malignancy Reports VL - 8 UR - https://doi.org/10.1007/s11899-013-0176-z DO - 10.1007/s11899-013-0176-z ID - Finazzi2013 ER - TY - JOUR AU - Tefferi, A. PY - 2012 DA - 2012// TI - Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management JO - American Journal of Hematology VL - 87 UR - https://doi.org/10.1002/ajh.23135 DO - 10.1002/ajh.23135 ID - Tefferi2012 ER - TY - JOUR AU - Hultcrantz, M. AU - Kristinsson, S. Y. AU - Andersson, T. M. AU - Landgren, O. AU - Eloranta, S. AU - Derolf, A. R. PY - 2012 DA - 2012// TI - Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study JO - Journal of Clinical Oncology VL - 30 UR - https://doi.org/10.1200/JCO.2012.42.1925 DO - 10.1200/JCO.2012.42.1925 ID - Hultcrantz2012 ER - TY - JOUR AU - Hultcrantz, M. AU - Wilkes, S. R. AU - Kristinsson, S. Y. AU - Andersson, T. M. AU - Derolf, A. R. AU - Eloranta, S. PY - 2015 DA - 2015// TI - Risk and cause of death in patients diagnosed with myeloproliferative neoplasms in Sweden between 1973 and 2005: a population-based study JO - Journal of Clinical Oncology ID - Hultcrantz2015 ER - TY - JOUR AU - Link, C. S. AU - Platzbecker, U. AU - Kroschinsky, F. AU - Pannach, S. AU - Thiede, C. AU - Platzek, I. PY - 2013 DA - 2013// TI - Association of oesophageal varices and splanchnic vein thromboses in patients with JAK2-positive myeloproliferative neoplasms: presentation of two cases and data from a retrospective analysis JO - Case Reports in Oncology VL - 6 UR - https://doi.org/10.1159/000352088 DO - 10.1159/000352088 ID - Link2013 ER - TY - JOUR AU - Campbell, P. J. AU - MacLean, C. AU - Beer, P. A. AU - Buck, G. AU - Wheatley, K. AU - Kiladjian, J. J. PY - 2012 DA - 2012// TI - Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2012-04-424911 DO - 10.1182/blood-2012-04-424911 ID - Campbell2012 ER - TY - JOUR AU - McMahon, B. AU - Stein, B. L. PY - 2013 DA - 2013// TI - Thrombotic and bleeding complications in classical myeloproliferative neoplasms JO - Seminars in Thrombosis and Hemostasis VL - 39 ID - McMahon2013 ER - TY - JOUR AU - Reikvam, H. AU - Tiu, R. V. PY - 2012 DA - 2012// TI - Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera JO - Leukemia VL - 26 UR - https://doi.org/10.1038/leu.2011.314 DO - 10.1038/leu.2011.314 ID - Reikvam2012 ER - TY - JOUR AU - Barbui, T. AU - Carobbio, A. AU - Cervantes, F. AU - Vannucchi, A. M. AU - Guglielmelli, P. AU - Antonioli, E. PY - 2010 DA - 2010// TI - Thrombosis in primary myelofibrosis: incidence and risk factors JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-08-238956 DO - 10.1182/blood-2009-08-238956 ID - Barbui2010 ER - TY - JOUR AU - Carobbio, A. AU - Finazzi, G. AU - Guerini, V. AU - Spinelli, O. AU - Delaini, F. AU - Marchioli, R. PY - 2007 DA - 2007// TI - Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-09-046342 DO - 10.1182/blood-2006-09-046342 ID - Carobbio2007 ER - TY - JOUR AU - Landolfi, R. AU - Gennaro, L. AU - Barbui, T. AU - Stefano, V. AU - Finazzi, G. AU - Marfisi, R. PY - 2007 DA - 2007// TI - Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-08-042515 DO - 10.1182/blood-2006-08-042515 ID - Landolfi2007 ER - TY - JOUR AU - Marchioli, R. AU - Finazzi, G. AU - Specchia, G. AU - Cacciola, R. AU - Cavazzina, R. AU - Cilloni, D. PY - 2013 DA - 2013// TI - Cardiovascular events and intensity of treatment in polycythemia vera JO - The New England Journal of Medicine VL - 368 UR - https://doi.org/10.1056/NEJMoa1208500 DO - 10.1056/NEJMoa1208500 ID - Marchioli2013 ER - TY - JOUR AU - Schwarz, J. AU - Ovesna, P. AU - Cerna, O. AU - Kissova, J. AU - Soukupova, J. M. AU - Brychtova, Y. PY - 2015 DA - 2015// TI - Thrombosis in thrombocythemic Ph- myeloproliferations is associated with higher platelet count prior to the event: results of analyses of prothrombotic risk factors from a registry of patients treated with anagrelide JO - European Journal of Haematology ID - Schwarz2015 ER - TY - JOUR AU - Vannucchi, A. M. AU - Guglielmelli, P. PY - 2013 DA - 2013// TI - JAK2 mutation-related disease and thrombosis JO - Seminars in Thrombosis and Hemostasis VL - 39 UR - https://doi.org/10.1055/s-0033-1343890 DO - 10.1055/s-0033-1343890 ID - Vannucchi2013 ER - TY - JOUR AU - Rumi, E. AU - Pietra, D. AU - Ferretti, V. AU - Klampfl, T. AU - Harutyunyan, A. S. AU - Milosevic, J. D. PY - 2014 DA - 2014// TI - JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes JO - Blood VL - 123 UR - https://doi.org/10.1182/blood-2013-11-539098 DO - 10.1182/blood-2013-11-539098 ID - Rumi2014 ER - TY - JOUR AU - Stefano, V. AU - Za, T. AU - Rossi, E. AU - Vannucchi, A. M. AU - Ruggeri, M. AU - Elli, E. PY - 2008 DA - 2008// TI - Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments JO - Haematologica VL - 93 UR - https://doi.org/10.3324/haematol.12053 DO - 10.3324/haematol.12053 ID - Stefano2008 ER - TY - JOUR AU - Genderen, P. J. AU - Leenknegt, H. AU - Michiels, J. J. AU - Budde, U. PY - 1996 DA - 1996// TI - Acquired von Willebrand disease in myeloproliferative disorders JO - Leukemia & Lymphoma. VL - 22 UR - https://doi.org/10.3109/10428199609074364 DO - 10.3109/10428199609074364 ID - Genderen1996 ER - TY - JOUR AU - Finazzi, G. AU - Budde, U. AU - Michiels, J. J. PY - 1996 DA - 1996// TI - Bleeding time and platelet function in essential thrombocythemia and other myeloproliferative syndromes JO - Leukemia & Lymphoma. VL - 22 UR - https://doi.org/10.3109/10428199609074363 DO - 10.3109/10428199609074363 ID - Finazzi1996 ER - TY - JOUR AU - Michiels, J. J. AU - Berneman, Z. AU - Schroyens, W. AU - Finazzi, G. AU - Budde, U. AU - Vliet, H. H. PY - 2006 DA - 2006// TI - The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera JO - Seminars in Thrombosis and Hemostasis VL - 32 UR - https://doi.org/10.1055/s-2006-949664 DO - 10.1055/s-2006-949664 ID - Michiels2006 ER - TY - JOUR AU - Moore, S. F. AU - Hunter, R. W. AU - Harper, M. T. AU - Savage, J. S. AU - Siddiq, S. AU - Westbury, S. K. PY - 2013 DA - 2013// TI - Dysfunction of the PI3 kinase/Rap1/integrin alpha(IIb)beta(3) pathway underlies ex vivo platelet hypoactivity in essential thrombocythemia JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-05-431288 DO - 10.1182/blood-2012-05-431288 ID - Moore2013 ER - TY - JOUR AU - Kreher, S. AU - Ochsenreither, S. AU - Trappe, R. U. AU - Pabinger, I. AU - Bergmann, F. AU - Petrides, P. E. PY - 2014 DA - 2014// TI - Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (OGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.) JO - Annals of Hematology VL - 93 UR - https://doi.org/10.1007/s00277-014-2224-8 DO - 10.1007/s00277-014-2224-8 ID - Kreher2014 ER - TY - BOOK AU - Hulcrantz, M. AU - Andersson, T. M. -. L. AU - Landgren, O. AU - Derolf, A. R. AU - Dickman, P. W. AU - Björkholm, M. PY - 2014 DA - 2014// TI - Risk of arterial and venous thrombosis in 11,155 patients with myeloproliferative neoplasms and 44,620 matched controls; a population-based study. 56th ASH annual meeting and exposition PB - American Society of Hematology CY - San Francisco ID - Hulcrantz2014 ER - TY - JOUR AU - Marchioli, R. AU - Finazzi, G. AU - Landolfi, R. AU - Kutti, J. AU - Gisslinger, H. AU - Patrono, C. PY - 2005 DA - 2005// TI - Vascular and neoplastic risk in a large cohort of patients with polycythemia vera JO - Journal of Clinical Oncology VL - 23 UR - https://doi.org/10.1200/JCO.2005.07.062 DO - 10.1200/JCO.2005.07.062 ID - Marchioli2005 ER - TY - JOUR AU - Elliott, M. A. AU - Tefferi, A. PY - 2005 DA - 2005// TI - Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia JO - British Journal of Haematology VL - 128 UR - https://doi.org/10.1111/j.1365-2141.2004.05277.x DO - 10.1111/j.1365-2141.2004.05277.x ID - Elliott2005 ER - TY - JOUR AU - Kiladjian, J. J. AU - Cervantes, F. AU - Leebeek, F. W. AU - Marzac, C. AU - Cassinat, B. AU - Chevret, S. PY - 2008 DA - 2008// TI - The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-11-125328 DO - 10.1182/blood-2007-11-125328 ID - Kiladjian2008 ER - TY - JOUR AU - Patel, R. K. AU - Lea, N. C. AU - Heneghan, M. A. AU - Westwood, N. B. AU - Milojkovic, D. AU - Thanigaikumar, M. PY - 2006 DA - 2006// TI - Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome JO - Gastroenterology VL - 130 UR - https://doi.org/10.1053/j.gastro.2006.04.008 DO - 10.1053/j.gastro.2006.04.008 ID - Patel2006 ER - TY - JOUR AU - Barbui, T. AU - Finazzi, M. C. AU - Finazzi, G. PY - 2012 DA - 2012// TI - Front-line therapy in polycythemia vera and essential thrombocythemia JO - Blood Reviews VL - 26 UR - https://doi.org/10.1016/j.blre.2012.06.002 DO - 10.1016/j.blre.2012.06.002 ID - Barbui2012 ER - TY - JOUR AU - Harrison, C. N. AU - Campbell, P. J. AU - Buck, G. AU - Wheatley, K. AU - East, C. L. AU - Bareford, D. PY - 2005 DA - 2005// TI - Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia JO - The New England Journal of Medicine VL - 353 UR - https://doi.org/10.1056/NEJMoa043800 DO - 10.1056/NEJMoa043800 ID - Harrison2005 ER - TY - JOUR AU - Gisslinger, H. AU - Gotic, M. AU - Holowiecki, J. AU - Penka, M. AU - Thiele, J. AU - Kvasnicka, H. M. PY - 2013 DA - 2013// TI - Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET study, a randomized controlled trial JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-07-443770 DO - 10.1182/blood-2012-07-443770 ID - Gisslinger2013 ER - TY - JOUR AU - Das, A. AU - Liu, D. PY - 2015 DA - 2015// TI - Novel antidotes for target specific oral anticoagulants JO - Experimental Hematology & Oncology. VL - 4 UR - https://doi.org/10.1186/s40164-015-0020-3 DO - 10.1186/s40164-015-0020-3 ID - Das2015 ER - TY - JOUR AU - Hoekstra, J. AU - Bresser, E. L. AU - Smalberg, J. H. AU - Spaander, M. C. AU - Leebeek, F. W. AU - Janssen, H. L. PY - 2011 DA - 2011// TI - Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms JO - Journal of Thrombosis and Haemostasis VL - 9 UR - https://doi.org/10.1111/j.1538-7836.2011.04484.x DO - 10.1111/j.1538-7836.2011.04484.x ID - Hoekstra2011 ER - TY - JOUR AU - Ellis, M. H. AU - Lavi, N. AU - Vannucchi, A. AU - Harrison, C. PY - 2014 DA - 2014// TI - Treatment of thromboembolic events coincident with the diagnosis of myeloproliferative neoplasms: a physician survey JO - Thrombosis Research VL - 134 UR - https://doi.org/10.1016/j.thromres.2014.04.032 DO - 10.1016/j.thromres.2014.04.032 ID - Ellis2014 ER - TY - JOUR AU - Nennecke, A. AU - Wienecke, A. AU - Kraywinkel, K. PY - 2014 DA - 2014// TI - Leukemia incidence and survival in Germany according to current standardized categories JO - Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz VL - 57 UR - https://doi.org/10.1007/s00103-013-1869-0 DO - 10.1007/s00103-013-1869-0 ID - Nennecke2014 ER - TY - JOUR AU - Passamonti, F. AU - Rumi, E. AU - Pungolino, E. AU - Malabarba, L. AU - Bertazzoni, P. AU - Valentini, M. PY - 2004 DA - 2004// TI - Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia JO - The American Journal of Medicine VL - 117 UR - https://doi.org/10.1016/j.amjmed.2004.06.032 DO - 10.1016/j.amjmed.2004.06.032 ID - Passamonti2004 ER - TY - JOUR AU - Barosi, G. AU - Lupo, L. AU - Rosti, V. PY - 2012 DA - 2012// TI - Management of myeloproliferative neoplasms: from academic guidelines to clinical practice JO - Current Hematologic Malignancy Reports VL - 7 UR - https://doi.org/10.1007/s11899-011-0109-7 DO - 10.1007/s11899-011-0109-7 ID - Barosi2012 ER - TY - JOUR AU - Stein, B. L. AU - Rademaker, A. AU - Spivak, J. L. AU - Moliterno, A. R. PY - 2011 DA - 2011// TI - Gender and vascular complications in the JAK2 V617F-positive myeloproliferative neoplasms JO - Thrombosis. VL - 2011 UR - https://doi.org/10.1155/2011/874146 DO - 10.1155/2011/874146 ID - Stein2011 ER - TY - JOUR AU - Barbui, T. AU - Barosi, G. AU - Birgegard, G. AU - Cervantes, F. AU - Finazzi, G. AU - Griesshammer, M. PY - 2011 DA - 2011// TI - Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet JO - Journal of Clinical Oncology VL - 29 UR - https://doi.org/10.1200/JCO.2010.31.8436 DO - 10.1200/JCO.2010.31.8436 ID - Barbui2011 ER - TY - JOUR AU - Vannucchi, A. M. AU - Kiladjian, J. J. AU - Griesshammer, M. AU - Masszi, T. AU - Durrant, S. AU - Passamonti, F. PY - 2015 DA - 2015// TI - Ruxolitinib versus standard therapy for the treatment of polycythemia vera JO - The New England Journal of Medicine VL - 372 UR - https://doi.org/10.1056/NEJMoa1409002 DO - 10.1056/NEJMoa1409002 ID - Vannucchi2015 ER -